Measure Information Form

Similar documents
Measure Information Form

Measure Information Form

Measure Information Form Collected For: CMS Voluntary Only The Joint Commission - Retired

Measure Information Form

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form

Measure Information Form

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Voluntary Only

Control emergence of drug-resistant. Reduce costs

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Voluntary Only

Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia

IMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP)

Antibiotics Use And Concordance To Guidelines For Patients Hospitalized With Community Acquired Pneumonia (CAP)

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Voluntary Only

Initial Antibiotic Selection and Patient Outcomes: Observations from the National Pneumonia Project

Measure Information Form

National Hospital Quality Measures Measure Definitions

Reducing Time to Initial Antibiotic Dose in Pneumonia Patients

Antimicrobial Stewardship:

Antimicrobial Stewardship: Stopping the Spread of Antibiotic Resistance

MAGNITUDE OF ANTIMICROBIAL USE. Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges

Compliance with antibiotic treatment guidelines in managed care patients with communityacquired pneumonia in ambulatory settings

ESISTONO LE HCAP? Francesco Blasi. Sezione Medicina Respiratoria Dipartimento Toraco Polmonare e Cardiocircolatorio Università degli Studi di Milano

JOINT CONFERENCE COMMITTEE CORE MEASURE UPDATE APRIL 13, 2010

2019 OPTIONS FOR INDIVIDUAL MEASURES: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose

The Three R s Rethink..Reduce..Rocephin

Use of Indicators to Evaluate the Quality of Community-Acquired Pneumonia Management

The Core Elements of Antibiotic Stewardship for Nursing Homes

Evaluating the Role of MRSA Nasal Swabs

Antimicrobial Stewardship

Barriers to Intravenous Penicillin Use for Treatment of Nonmeningitis

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM

ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies

Methicillin-Resistant Staphylococcus aureus Nasal Swabs as a Tool in Antimicrobial Stewardship

Study of Fluoroquinolone Usage Sensitivity and Resistance Patterns

MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative

Pneumonia considerations Galia Rahav Infectious diseases unit Sheba medical center

Quality ID #352: Total Knee Replacement: Preoperative Antibiotic Infusion with Proximal Tourniquet National Quality Strategy Domain: Patient Safety

Bai-Yi Chen MD. FCCP

Outcomes in lower respiratory tract infections and the impact of antimicrobial drug resistance Joshua P. Metlay 1 and Daniel E.

Antimicrobial Stewardship Strategy: Intravenous to oral conversion

UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients

Developed by Kathy Wonderly RN, MSEd,CPHQ Developed: October 2009 Most recently updated: December 2014

Core Elements of Antibiotic Stewardship for Nursing Homes

Treatment Duration for Uncomplicated Community-Acquired Pneumonia: The Evidence in Support of 5 Days

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority

Stewardship: Challenges & Opportunities in the Gulf Region

AND MISCONCEPTIONS IN THE MANAGEMENT OF SEPSIS

EVIDENCE BASED MEDICINE: ANTIBIOTIC RESISTANCE IN THE ELDERLY CHETHANA KAMATH GERIATRIC MEDICINE WEEK

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012

Safety of an Out-Patient Intravenous Antibiotics Programme

What is an Antibiotic Stewardship Program?

Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia

Suitability of Antibiotic Treatment for CAP (CAPTIME) The duration of antibiotic treatment in community acquired pneumonia (CAP)

Antimicrobial stewardship: Quick, don t just do something! Stand there!

Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial

Objectives 4/26/2017. Co-Investigators Sadie Giuliani, PharmD, BCPS Claude Tonnerre, MD Jayme Hartzell, PharmD, MS, BCPS

Antimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority

Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.

Membre du Groupe Jolimont

The Role of the Staff Pharmacist in Antimicrobial Stewardship

prof. dr. Bojana Beović, dr. med.

Antibiotic stewardship in long term care

Hot Topics in Antimicrobial Stewardship. Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority

Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals

Antibiotic Stewardship Beyond Hospital Walls

Jump Start Stewardship

GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS

Success for a MRSA Reduction Program: Role of Surveillance and Testing

The Impact of meca Gene Testing and Infectious Diseases Pharmacists. Intervention on the Time to Optimal Antimicrobial Therapy for ACCEPTED

Sustaining an Antimicrobial Stewardship

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority

CMS Antibiotic Stewardship Initiative

Antibiotic Stewardship and Critical Access Hospitals. Robert White, BA, PT, CPHQ Program Manager TMF Quality Innovation Network

Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities

Understand the application of Antibiotic Stewardship regulations in LTC. Understand past barriers to antibiotic management concepts

NUOVE IPOTESI e MODELLI di STEWARDSHIP

INFECTIOUS DISEASES STRATEGIES TO LIMIT HOSPITALIZATION,REDUCE RISK AND ADD VALUE

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Potential Conflicts of Interest. Schematic. Reporting AST. Clinically-Oriented AST Reporting & Antimicrobial Stewardship

Antimicrobial Stewardship: Setting minimum expectations for optimizing antimicrobial use and addressing resistance

CLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met:

An algorithm to determine. antimicrobial therapy based

Geriatric Mental Health Partnership

Algorithm To Determine Cost Savings of Targeting Antimicrobial Therapy Based on Results of Rapid Diagnostic Testing

Quality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction

Update on CDC Antibiotic Stewardship Activities

Antibiotic Therapy for Adults Hospitalized With Community-Acquired Pneumonia A Systematic Review

Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection Quenzer R W, Pettit K G, Arnold R J, Kaniecki D J

See Important Reminder at the end of this policy for important regulatory and legal information.

Antibiotics: Take a Time Out

Telligen Outpatient Antibiotic Stewardship Initiative. The Renal Network March 1, 2017

ESCMID Online Lecture Library. by author

NHSN 2015 Rebaseline and TDH Updates. Ashley Fell, MPH

OBJECTIVES. Fast Facts 3/23/2017. Antibiotic Stewardship Beyond Hospital Walls. Antibiotics are a shared resource and becoming a scarce resource.

Transcription:

Release Notes: Measure Information Form Version 2.0 Measure Information Form Measure Set: Pneumonia (PN) Set Measure ID #: Organization Set Measure ID# Time Intervals JCHO 0-8 hours CMS/JCHO 0-4 hours Performance Measure Name: () Initial ntibiotic Received Within 8 Hours of Hospital rrival () Initial ntibiotic Received Within 4 Hours of Hospital rrival (NQF-ENDORSED VOLUNTRY CONSENSUS STNDRDS FOR HOSPITL CRE) Description: () Pneumonia patients who receive their first dose of antibiotics within 8 hours after arrival at the hospital () Pneumonia patients who receive their first dose of antibiotics within 4 hours after arrival at the hospital Rationale: There is growing clinical evidence of an association between timely inpatient administration of antibiotics and improved outcome among pneumonia patients. One study found that Medicare pneumonia patients had improved survival if they received antibiotics within 4 hours of admission (Khan 1990). nother study found that shortening the time-to-firstdose to 4 hours was associated with improved survival (McGarvey 1993). In 1995 over 14,000 randomly selected Medicare pneumonia hospitalizations were examined. They found that patients who received their first dose of antibiotic within 3 hours were less likely to die within 30 days than were patients whose antibiotics were delayed, although this association did not become statistically significant until 8 hours following arrival, when a 15% (P<0.001) reduction was noted (Meehan 1995). More recently, a study of 13,771 Medicare pneumonia hospitalizations from 1998-99 found that 30-day mortality was 10% (P=0.04) lower and length of hospital stay was shorter among patients whose first antibiotic was administered within 4 hours when compared with those whose time to first dose was longer. mong patients who had not received antibiotics before arriving at the hospital, administration within 4 hours was associated with 17% reductions in mortality during both hospitalization (P=0.01) and the 30 days following admission (P=0.001) (ratzler 2001). ased on these studies, the Infectious Diseases Society of merica (2000) and the merican Thoracic Society (2001) suggests 8 hours as the maximum time to first antibiotic administration. Data collected by the National Pneumonia Project indicate that among Medicare pneumonia patients age 65 or older who were hospitalized during 1998-99, the first dose was administered within 8 hours for 83.4%, within 6 hours for 74.9%, and within 4 hours for 57.7%. This b-1

represents a significant improvement from 1995, when corresponding rates were 79.4% at 8 hours, 68.8% at 6 hours, and 49.9% at 4 hours (CMS unpublished data). For 1998-99, the rates of administration within 8 hours ranges from 38% to 91% among the states and territories. Type of Measure: Process Improvement Noted s: n increase in the rate Numerator Statement: Number of pneumonia patients who received their first antibiotic dose within a specified timeframe (as specified under the Set Measure Identifier and description above) from hospital arrival Included s: Not pplicable Excluded s: None Data Elements: ntibiotic dministration Date ntibiotic dministration Time ntibiotic Name rrival Date rrival Time Denominator Statement: Pneumonia patients 18 years of age and older Included s: Discharges with: n Principal Diagnosis Code of pneumonia as defined in ppendix, Table 3.1 OR Principal Diagnosis Code of septicemia or respiratory failure (acute or chronic) as defined in ppendix, Tables 3.2, or 3.3 ND n Other Diagnosis Code of pneumonia (ppendix, Table 3.1) Excluded s: Patients received in transfer from another acute care or critical access hospital, including another emergency department Patients who had no working diagnosis of pneumonia at the time of admission Patients receiving Comfort Measures Only Patients who do not receive antibiotics during hospitalization or within 36 hours (2160 minutes) from the time of hospital arrival Patients who have received antibiotics within 24 hours prior to hospital arrival Patients less than 18 years of age Patients involved in protocols or clinical trials Patients who had no chest x-ray or CT scan that indicated positive infiltrate within 24 hours prior to hospital arrival or anytime during this hospitalization b-2

Data Elements: dmission Date dmission Source ntibiotic dministration Date ntibiotic dministration Time ntibiotic Name ntibiotic Received ntibiotics Prior to rrival irthdate Chest X-Ray Clinical Trial Comfort Measures Only Other Diagnosis Codes Principal Diagnosis Code Pneumonia Working Diagnosis on dmission Transfer From nother ED Risk djustment: No Data Collection pproach: Retrospective data sources for required data elements include administrative data and medical record documents. Some hospitals may prefer to gather data concurrently by identifying patients in the population of interest. This approach provides opportunities for improvement at the point of care/service. However, complete documentation includes the principal and other diagnosis and procedure codes, which require retrospective data entry. Data ccuracy: Variation may exist in the assignment of codes; therefore, coding practices may require evaluation to ensure consistency. Health care organizations may want to work with their hospital pharmacy to identify and list the antibiotics that are used in their organization. This list can serve as a reference for the abstractor. To be part of the measure population, a patient must have received an antibiotic during the hospitalization. The date and time for the initial antibiotic refer to the initial antibiotic administered during the hospital stay, not the antibiotic taken prior to hospital arrival. Measure nalysis Suggestions: Health care organizations should investigate any patients whose time to antibiotic administration was greater than 2160 minutes (36 hours) for a possible data entry error or a performance improvement opportunity. This measure seeks to identify the timing of the first antibiotic administered. It is important to note that the measure focuses on the administration of any antibiotic, not necessarily the antibiotic consistent with consensus guidelines. Therefore, data from this measure should be reviewed in conjunction with PN-6, PN-6a, and PN-6b that address appropriate antibiotic b-3

selections. For example, an HCO could receive excellent indicator rates for antibiotic administered timing but low rates for giving the appropriate antibiotics consistent with guidelines. Sampling: Yes, for additional information see the Sampling Section. Data Reported as: ggregate rate generated from count data reported as a proportion Selected References: artlett JG, Dowell SF, Mandell L, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of merica. Clin Infect Dis. 2000;31:347-382. ratzler, DW, Houck PM, Nsa W, et al. Initial processes of care and outcomes in elderly patients with pneumonia. {abstract} merican College of Emergency Physicians Research Forum, October 15, 2001, Chicago, IL. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, Plouffle JF, Rakowsky, Schuchat, Whitney C and the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group, Management of Community-cquired Pneumonia in the Era of Pneumococcal Resistance: Report From the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. rch Intern Med, 160:1399-1408, May 22, 2000. Houck PM, ratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. rch Intern Med 2004; 164: 637-644. Khan KL, Rogers WH, Rubenstein LV, et al. Measuring quality of care with explicit process criteria before and after implementation of the DRG-based prospective payment system. JM. 1990:264:1969-1973. Mandell L, artlett JG, Dowell SF, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of merica. Clin Infect Dis. 2003;37:1405-1433. McGarvey RN, Harper JJ. Pneumonia mortality reduction and quality improvement in a community hospital. Qual Rev ull. 1993;19:124-130. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process and outcomes in elderly patients with pneumonia. JM. 1997;278:2080-2084. Niederman MS, Mandell L, nzueto, et al. Guidelines for the management of adults with community-acquired pneumonia. merican Thoracic Society. m. J. Respir. Crit. Care Med. 2001;163:1730-1754. b-4

: Initial ntibiotic Received Within 8 Hours Of Hospital rrival. Numerator: Number of Pneumonia patients who received their first antibiotic dose within 8 hours from hospital arrival. Denominator: Pneumonia patients 18years age and older. Variable Key: Patient ge Initial ntibiotic Date Start Initial ntibiotic Time bxtiming Principal Diagnosis Code Table 3.1 Principal Diagnosis Code Table 3.2 Principal Diagnosis Code Table 3.3 On Table 3.1 On Table 3.2 On Table 3.3 ll Other Diagnosis Codes Missing or Table 3.1 On Table 3.1 dmission Date irthdate Patient ge(in years) = dmission Date minus irthdate Note: The algorithm to calculate age must use the month and day portion of admission date and birthdate to yield the most accurate age. age < 0 days (negative value) Patient ge age > or = 0 days and < 18 years age >= 18 years Chest X-Ray Pneumonia Working Diagnosis on dmission Comfort Measures Only (Initial population, common to all measures in the PN set) H b-5

H Transfer From nother ED dmission Source = 4, or D = 1,2,3,5,6,7,8 or 9 Clinical Trial rrival Date rrival Time I b-6

I ntibiotic Received = 1 or 4 = 2 or 3 ntibiotics Prior to rrival for all antibiotics ntibiotic Name On table 2.1 for at least one antibiotic Note: Proceed only with antibiotics that have a valid name on table 2.1 Missing/ for all antibiotics ntibiotic dministration Date for at least one antibiotic Note: Proceed only with ntibiotics that have valid ntibiotic dministration Dates Initial ntibiotic Date= The ntibiotic dministration Date that corresponds to the initial antibiotic dose. Note: The initial antibiotic dose is the earliest antibiotic dose administered. If there is more than one antibiotic on the earliest date, select the one having a valid ntibiotic dministration Time. If the earliest antibiotic dose has a date but no time, it should be considered to be the initial antibiotic dose. Missing or Measure Data Missing/ for the antibiotic considered for the Initial ntibiotic Date ntibiotic dministration Time for antibiotics with valid dates Initial ntibiotic Time= The ntibiotic dministration Time that corresponds to the initial antibiotic dose. bxtiming = Initial ntibiotic Date and Initial ntibiotic Time minus rrival Date and rrival Time (in minutes) bxtiming < -15 minutes or > 2160 minutes Not In Measure Measure DIn > or = -15 minutes and < or = 2160 minutes E > 480 minutes Initial >or = -15 minutes and In Numerator ntibiotic < or = 480 minutes Timing Stop b-7

: Initial ntibiotic Received Within 4 Hours Of Hospital rrival. Numerator: Number of Pneumonia patients who received their first antibiotic dose within 4 hours from hospital arrival. Denominator: Pneumonia patients 18 years of age and older. Variable Key: Patient ge Start Initial ntibiotic Date Initial ntibiotic Time bxtiming Principal Diagnosis Code Table 3.1 Principal Diagnosis Code Table 3.2 Principal Diagnosis Code Table 3.3 On Table 3.1 On Table 3.2 On Table 3.3 ll Other Diagnosis Codes Missing or Table 3.1 On Table 3.1 dmission Date irthdate Patient ge(in years) = dmission Date minus irthdate Note: The algorithm to calculate age must use the month and day portion of admission date and birthdate to yield the most accurate age. age < 0 days (negative value) Patient ge age > or = 0 days and < 18 years age >= 18 years Chest X-Ray Pneumonia Working Diagnosis on dmission Comfort Measures Only (Initial population, common to all measures in the PN set) H b-8

H Transfer From nother ED dmission Source = 4, or D = 1,2,3,5,6,7,8 or 9 Clinical Trial rrival Date rrival Time I b-9

I ntibiotic Received = 1 or 4 = 2 or 3 ntibiotics Prior to rrival for all antibiotics ntibiotic Name On table 2.1 for at least one antibiotic Note: Proceed only with antibiotics that have a valid name on table 2.1 Missing/ for all antibiotics ntibiotic dministration Date for at least one antibiotic Note: Proceed only with ntibiotics that have valid ntibiotic dministration Dates Initial ntibiotic Date= The ntibiotic dministration Date that corresponds to the initial antibiotic dose. Note: The initial antibiotic dose is the earliest antibiotic dose administered. If there is more than one antibiotic on the earliest date, select the one having a valid ntibiotic dministration Time. If the earliest antibiotic dose has a date but no time, it should be considered to be the initial antibiotic dose. Missing or Measure Data for the antibiotic considered for the Initial ntibiotic Date ntibiotic dministration Time for antibiotics with valid dates Initial ntibiotic Time= The ntibiotic dministration Time that corresponds to the initial antibiotic dose. bxtiming = Initial ntibiotic Date and Initial ntibiotic Time - rrival Date and rrival Time (in minutes) bxtiming < -15 minutes or > 2160 minutes Not In Measure Measure DIn > or = -15 minutes and < or = 2160 minutes E > 240 minutes Initial >or = -15 minutes and In Numerator ntibiotic < or = 240 minutes Timing Stop b-10